inebilizumab April 12, 2017 inebilizumab Trade Name Orphan Indication Scleroderma USA Market Approval USA USA Designation Date 2009-12-03 00:00:00 Sponsor MedImmune;One MedImmune Way;Gaithersburg, Maryland, 20878
